37 related articles for article (PubMed ID: 14760126)
1. Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.
Horowitz NS; Deng W; Peterson I; Mannel RS; Thompson S; Lokich E; Myers T; Hanjani P; O'Malley DM; Chung KY; Miller DS; Ueland FR; Dizon DS; Miller A; Mayadev JS; Leath CA; Monk BJ
J Clin Oncol; 2024 Jun; 42(16):1914-1921. PubMed ID: 38574312
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas.
Tang S; Zhao L; Wu XB; Wang Z; Cai LY; Pan D; Li Y; Zhou Y; Shen Y
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010978
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma.
Huo RX; Jin YY; Zhuo YX; Ji XT; Cui Y; Wu XJ; Wang YJ; Zhang L; Zhang WH; Cai YM; Zheng CC; Cui RX; Wang QY; Sun Z; Wang FW
World J Clin Cases; 2022 Apr; 10(11):3414-3425. PubMed ID: 35611190
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.
Popovtzer A; Normolle D; Worden FP; Prince ME; Chepeha DB; Wolf GT; Bradford CR; Lawrence TS; Eisbruch A
Transl Oncol; 2014 Aug; 7(4):479-83. PubMed ID: 25171890
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study.
Granados García M; Chilaca Rosas MF; Lavín Lozano AJ; Maldonado Magos F; Frías Mendivil M; Cabrera Aquino G; Segura Pacheco BA; Montes Luis MM; Olvera Caraza D; Aguilar Ponce JL
Clin Transl Oncol; 2011 Feb; 13(2):109-14. PubMed ID: 21324799
[TBL] [Abstract][Full Text] [Related]
6. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study.
Halim AA; Wahba HA; El-Hadaad HA; Abo-Elyazeed A
Med Oncol; 2012 Mar; 29(1):279-84. PubMed ID: 21279703
[TBL] [Abstract][Full Text] [Related]
7. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
Sun Q; Zheng X; Zhang L; Yu J
Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
Alvarado-Miranda A; Arrieta O; Gamboa-Vignolle C; Saavedra-Perez D; Morales-Barrera R; Bargallo-Rocha E; Zinser-Sierra J; Perez-Sanchez V; Ramirez-Ugalde T; Lara-Medina F
Radiat Oncol; 2009 Jul; 4():24. PubMed ID: 19591689
[TBL] [Abstract][Full Text] [Related]
9. Adenoid cystic carcinoma of the tongue--clinicopathological study and survival analysis.
Luna-Ortiz K; Carmona-Luna T; Cano-Valdez AM; Mosqueda-Taylor A; Herrera-Gómez A; Villavicencio-Valencia V
Head Neck Oncol; 2009 May; 1():15. PubMed ID: 19480697
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.
Benasso M; Merlano M; Sanguineti G; Corvò R; Numico G; Ricci I; Pallestrini E; Santelli A; Vitale V; Marchetti G; Rosso R
Am J Clin Oncol; 2001 Dec; 24(6):618-22. PubMed ID: 11801767
[TBL] [Abstract][Full Text] [Related]
11. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J
Oncologist; 2016 Jan; 21(1):59-71. PubMed ID: 26712958
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization by gemcitabine.
Lawrence TS; Eisbruch A; McGinn CJ; Fields MT; Shewach DS
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):55-60. PubMed ID: 10550827
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Ali EM; Abdelraheem AG
Head Neck Oncol; 2011 Nov; 3():48. PubMed ID: 22085617
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
